| Typicality: | 0.454 |
| Saliency: | 0.479 |
| with the comprehensive analysis of each | 75 | other |
| broadly | 3 | degree |
| based on clinical trial phase | 2 | other |
| market → be categorized into → different segments | 62 |
| market → be classified into → different segments | 19 |
| market → be divided into → various segments | 7 |
| market → be divided into → following segments | 4 |
| market → be categorized in → multiple segments | 3 |
| market → be categorized into → major segments | 3 |
| negative | neutral | positive |
| 0.032 | 0.896 | 0.072 |
| Raw frequency | 98 |
| Normalized frequency | 0.479 |
| Modifier score | 0.500 |
| Perplexity | 162.927 |